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Available online 4 January 2014Abstract Pluripotent stem cells can be derived from preimplantation and postimplantationmouse embryos. Embryonic stem cells
(ESCs) derived from blastocysts are in a “naive” pluripotent state and meet all of the criteria for pluripotency, including the ability
to generate live pups through tetraploid complementation. Epiblast stem cells (EpiSCs) derived from postimplantation epiblasts are
in a “primed” pluripotent state. ESCs and EpiSCs show different phenotypes and gene expression patterns, and EpiSCs are thought to
be less pluripotent than ESCs. In this study, we addressed whether EpiSCs can be differentiated into specialized cell types in vitro.
To do this, we first derived EpiSCs from E5.5–6.5 mouse embryos containing the Oct4-GFP transgene. We found that EpiSCs
expressed pluripotency markers and differentiated into all three germ layers in intro and in vivo. Interestingly, EpiSCs also
efficiently differentiated into a homogenous population of neural stem cells (NSCs) in vitro. The EpiSC-derived NSCs (EpiSC-NSCs)
expressed NSC markers (Nestin, Sox2, and Musashi), self-renewed for more than 20 passages, and differentiated into neuronal and
glial neural cell subtypes in vitro. We then transplanted the EpiSC-NSCs into the neonatal mouse brains, and found that they were
able to survive and differentiate into robust neurons and glial cells in the mouse brains, demonstrating that primed pluripotent
EpiSCs efficiently form functional NSCs. We compared the global gene expression patterns of NSCs differentiated from EpiSC-NSCs,
ESCs, and brain tissue and found that the expression patterns of most genes, including pluripotency and NSC specificity, were
similarly clustered, but that the developmental process-related genes were distantly clustered. Moreover, the global gene
expression pattern of brain-derived NSCs was more similar to that of ESC-derived NSCs than that of EpiSC-derived NSCs. Taken
together, these results indicate that althoughNSCs, regardless of their origins, display very similar in vitro and in vivo differentiation
properties, their global gene expression profiles may differ, depending on the pluripotency state, i.e., naive or primed.
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Pluripotent stem cells can be classified into two distinct
pluripotent states, i.e., “naive” and “primed.” Cells of the
inner cell mass (ICM) of the blastocyst and epiblast cells
are the pluripotent cells in early embryonic development.er B.V. All rights reserved.
507Embryonic stem cells (ESCs) derived from ICM of blastocyst
are naive pluripotent (Nichols and Smith, 2009) and epiblast
stem cells (EpiSCs) derived from postimplantation epiblast
cells are primed pluripotent. Naive pluripotent mouse
ESCs are maintained in a pluripotent state by signaling
through the STAT3 and bone morphogenetic protein 4
(BMP4) pathways. These cells contribute to all three germ
layers (including germ cells) in vitro and in vivo and efficiently
form chimeric mice (Meissner et al., 2008; Nichols and Smith,
2009; Ying et al., 2008). By contrast, the primed pluripotent
EpiSCs aremaintained in a pluripotent and self-renewing state
by signaling through basic fibroblast growth factor (bFGF)
and Activin/Nodal (Brons et al., 2007; Vallier et al., 2009);
however, EpiSCs barely contribute to chimeras when injected
into blastocysts, the efficiency of chimera formation being
as low as 0.5% (2/385) (Brons et al., 2007). EpiSCs and ESCs
also differ in other aspects, including colony morphology
(Stadtfeld and Hochedlinger, 2010), specific marker expres-
sion patterns (Guo et al., 2009; Han et al., 2011; Jouneau
et al., 2012), and the number of active X chromosomes in
female cells (Gardner et al., 1985). Human ESCs (hESCs)
derived from preimplantation blastocysts are more similar
to mouse EpiSCs than to mouse ESCs in terms of their
flat morphology, signaling requirements for maintenance
of pluripotency, and X chromosome inactivation status (Aoki
et al., 2009; Hanna et al., 2010a; Silva et al., 2008).
However, the state of pluripotency is not stringent, because
EpiSCs can be produced from blastocysts in culture (Najm
et al., 2011a), and EpiSCs and hESCs can be converted
into naive pluripotent state as mouse ESCs by genetic
manipulation or treatment with small molecules (Gillich
et al., 2012; Hanna et al., 2010a, 2010b).
EpiSCs could be differentiated into all three germ layers
in vitro and in vivo; however, it is not yet known whether
EpiSCs can differentiate into specialized cell types in vitro.
Recently, Najm et al. showed that EpiSCs could differentiate
into oligodendrocyte progenitor cells that subsequently
upregulated oligodendrocyte-specific genes and differenti-
ated into oligodendrocytes in vitro (Najm et al., 2011b).
However, it is not yet known whether EpiSCs are able to
differentiate into NSCs in vitro.
In this study, we confirm that EpiSCs can be differentiated
into NSCs in vitro. We show that EpiSC-derived NSCs expressed
the NSC markers Nestin, Sox2, and Musashi, and self-renewed
for more than 20 passages in vitro. EpiSC-derived NSCs were
indistinguishable from brain-derived NSCs and ESC-derived
NSCs in their morphological characteristics, differentiation
potential, and NSC-related gene expression. We also exam-
ined the global gene expression profiles of NSCs derived from
EpiSC, ESC, and brain.Materials and methods
Culture of EpiSC
Epiblasts were obtained from OG2 heterozygous embryos
at embryonic day 6.5 (E6.5). OG2 mice express GFP under
the control of the Oct4 promoter and a distal enhancer. All
mouse strains were bred and housed at the mouse facility
of Konkuk University or were bought from The Jackson
Laboratory (Sacramento, CA, USA). Animal handling wasdone in accordance with the animal protection guidelines of
the Konkuk University and the Korean animal protection
laws. The decidua were removed from the pregnant mouse
with a needle, and the extraembryonic ectoderm was
separated from the epiblast with hand-pulled glass pipettes.
The epiblast was washed with PBS and cultured on a layer
of inactivated mouse embryonic fibroblasts (MEFs) in EpiSC
medium (Brons et al., 2007), consisting of DMEM/F12
supplemented with 20% KnockOut Serum Replacement (both
from Gibco), 2 mM glutamine, nonessential amino acids,
20 ng/ml activin A (PeproTech), and 5 ng/ml basic fibroblast
growth factor (bFGF; Invitrogen). EpiSCs were passaged every
3 to 4 days by dissociation with 1 mg/ml collagenase type IV
(Invitrogen) or by pipetting with a glass pipette.
Derivation of NSCs from EpiSCs
For NSC induction, EpiSCs were cultured in neural induction
medium (DMEM/F12 [Invitrogen] supplemented with 20%
KSR [Invitrogen], 20 ng/ml activin A, and 12 ng/ml bFGF).
After 1 to 2 days, differentiated cells (identified by their
change in morphology) were transferred into the neurosphere
medium consisting of DMEM/F12 supplemented with N2
and B27 supplements (both Invitrogen), 2 mM glutamine,
1× penicillin/streptomycin/glutamine (Invitrogen), 20 ng/ml
EGF (Invitrogen), and 20 ng/ml bFGF, and cultured for 2 days
in suspension culture. Cells were then resuspended in
NSC expansion medium (DMEM/F12 supplemented with
N2 supplement, 10 ng/ml EGF, and bFGF, 50 μg/ml bovine
serum albumin [Invitrogen], and 1× penicillin/streptomycin/
glutamine) and cultured in a 0.1% gelatin-coated dish for
3 days.
Differentiation of NSCs into neurons and glial cells
Brain-, ESC-, or EpiSC-derived NSCs were differentiated
into neurons and glial cells by culturing for 3 weeks
in neuronal differentiation medium (DMEM/F12 medium,
Neurobasal medium [Invitrogen], 1% fetal bovine serum,
1× N2 supplement, 1× penicillin/streptomycin/glutamine,
and 50× B27 supplement).
Alkaline phosphatase assay
For alkaline phosphatase (AP) staining, cells were fixed with
4% paraformaldehyde for 1 min at room temperature, washed
with 0.05% Tween-20/PBS, and treated with AP solution
(Takara) for 15 min at RT.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde for 20 min at room
temperature, washedwith PBS, resuspended in PBS containing
10% normal goat serum and 0.03% Triton X-100, and treated
with primary antibodies for 45 min at room temperature. The
primary antibodies were anti-Oct4 (1:500 dilution; Chemicon,
Temecula, CA, USA), anti-Nanog (1:250; Chemicon), anti-
Nestin (1:200; Chemicon), anti-Sox2 (1:1000; Chemicon),
anti-Musashi (1:1000; Chemicon), anti-β-III tubulin (Tuj1,
1:1000; Chemicon), and anti-glial fibrillary acidic protein
508 H.J. Jang et al.(GFAP, 1:250; Chemicon). Cells were then incubated with
fluorescence-labeled secondary antibodies (Alexa Fluor 488
or 568; Molecular Probes, Eugene, OR, USA), according to
the manufacturer's specifications.
Teratoma formation
To confirm their ability to undergo differentiation in vivo,
EpiSCs (~1 × 106 cells) were injected into the testes of
SCID mice. Tumors were harvested surgically from the
euthanized mice at 4 weeks after injection. Teratomas
were fixed with 4% paraformaldehyde for 36 h at RT and
then sectioned using standard techniques. Sections were
stained with hematoxylin and eosin to identify the tissue
types.
RNA isolation and quantitative reverse-transcriptase
polymerase chain reaction (RT-PCR)
Total RNA was isolated using the RNeasy Mini Kit (Qiagen) and
treated with DNase to remove contaminating genomic DNA.
Samples of 1 μg total RNA were reverse transcribed with
a SuperScript III Reverse-Transcriptase Kit and oligo (dT)
primers (both Invitrogen) according to the manufacturer's
instructions. The primer sequences and annealing tempera-
tures were as follows: Oct4 sense 5′-TCTCCCATGCATTCA
AACTG and antisense 5′-GCTCCTGATCAACAGCATCA; Nanog
sense 5′-AAGTACCTCAGCCTCCAGCA and antisense 5′-GTGCTG
AGCCCTTCTGAATC; FGF5 sense 5′-GCGACGTTTTCTTCGTCTTC
and antisense 5′-ACAATCCCCTGAGACACAGC; Sox17 sense
5′-GGAGGGTCACCACTGCTTTA and antisense 5′-AGATGTC
TGGAGGTGCTGCT; Dkk1 sense 5′-GAGGGGAAATTGAGGAA
AGC and antisense 5′-GGTGCACACCTGACCTTCTT; and Rex1
sense 5′-CTGGTGGCAAGTATGTGGTG and antisense 5′-CAG
GAGTGTATGGCTCAGCA. Quantitative PCR reactions were
performed in duplicate using Power SYBR Green Master
Mix (Takara) and analyzed with a Roche LightCycler 5480
(Roche). Duplicate amplifications were carried out for each
target gene with three wells serving as negative controls.
Quantification was estimated using the comparative Ct
method normalized with β-actin and presented as a percent-
age of biological controls.
Methylation analysis
Genomic DNA was isolated from ESCs and EpiSCs and bisulfite
reactions were performed using an EpiTect Bisulfite Kit
(Qiagen) according to the manufacturer's instructions. PCR
amplification of Stella and Dppa5 promoter regions was
performed using the following primer sequences and anneal-
ing temperatures: Stella first primer pair, sense 5′-TTTTTT
TATTTTGTGATTAGGGTTG and antisense 5′-CTTCACCTAAAC
TACACCTTTAAAC (161 bp, 45 °C); Stella second primer pair,
sense 5′-TTTGTTTTAGTTTTTTTGGAATTGG and antisense 5′-CT
TCACCTAAACTACACCTTTAAAC (116 bp, 55 °C); Dppa5 first
primer pair, sense 5′-GGTTTGTTTTAGTTTTTTTAGGGGTATA
and antisense 5′-CCACAACTCCAAATTCAAAAAAT (140 bp,
45 °C); Dppa5 second primer pair, sense 5′-TTTAGTTTTT
TTAGGGGTATAGTTTG and antisense 5′-CTTCACCTAAAC
TACACCTTTAAAC (132 bp, 55 °C). The PCR products were
subcloned into pGEM-T Easy vector (Promega, Madison, WI)and sequenced. BiQ Analyzer software (Max Planck Institute,
Saarbrücken, Germany) was used to visualize and quantify the
bisulfite sequence data.
Transplantation of brain-, ESC-, and EpiSC-derived
NSCs
NSC transplantation was performed as described previously
(Deng et al., 2003, 2006). In brief, NSCs were stained with
bisbenzimide and transplanted into the lateral ventricle
of wild-type neonatal CF1 mice within 24 h of birth. For
transplantation, the pups were anesthetized by hypothermia
and placed in a clay mold. The head was transilluminated
under a dissection microscope, and a Hamilton syringe with
a beveled tip was lowered through the scalp and skull
immediately anterior to the bregma. Approximately 2.5 × 105
NSCs in 1 μl of DMEM/F12 were then slowly injected into
the left lateral ventricle under low pressure. Immediately
after injection, pups were warmed in a 37 °C incubator and
returned to themother approximately 30 min later. At 10 days
posttransplantation, mice were euthanized with an overdose
of Avertin and then transcardially perfused with 4% parafor-
maldehyde in PBS. The brain was excised, postfixed overnight
in 4% paraformaldehyde in PBS, and sectioned through the
coronal plane into 40-μm slices with a cryostat (Microm,
Walldorf, Germany).
Immunolabeling of brain sections
Forebrains were cut with a cryotome into 40-μm coronal
sections exhaustively and processed free-floating. After
blocking in PBS with 10% goat serum, sections were incubated
at 4 °C in primary antibodies against the neuron-specific
marker Tuj1(type III beta-tubulin; 1:500, BD Bioscience) or the
astrocyte-specific marker GFAP (glial fibrillary acidic protein;
1:500, BD Bioscience). The tissues were then washed in PBS
and incubated in the appropriate fluorescence-conjugated
secondary antibodies (goat anti-rabbit IgG-conjugated Alexa-
488, 1:200, Molecular Probes) for 1 h at room temperature.
After a final wash in PBS, the stained brain slices were
mounted onto glass slides, examined and photographed
using a confocal laser-scanning microscope imaging system
(LSM510, Carl Zeiss, Inc.).
Microarray-based analysis
Total RNA was isolated using an RNeasy Mini Kit (Qiagen) and
digested with DNase I (RNase-free DNase, Qiagen) according
to the manufacturer's instructions. Total RNA was amplified,
biotinylated, and purified using the Ambion Illumina RNA
amplification kit (Ambion), according to the manufacturer’s
instructions. Biotinylated cRNA samples (750 ng) were hybrid-
ized to eachMouseRef-8 v2 Expression BeadChip (Illumina) and
signals were detected using Amersham fluorolink streptavidin-
Cy3 (GE Healthcare Life Sciences) by following the Illumina
bead array protocol. Arrays were scanned with an Illumina
BeadArray Reader confocal scanning system according to the
manufacturer's instructions.
Raw data were extracted using the software provided
by the manufacturer (Illumina GenomeStudio v2011. 1, Gene
Expression Module v1.9. 0). Array data were filtered using a
509detection p-value of b0.05 in at least 50% of the samples.
The selected probe signal value was logarithmically trans-
formed and normalized using the quantile method. Com-
parative analyses were carried out using the LPE test
and fold change. The false discovery rate was controlled
by adjusting the p-values using the Benjamini–Hochberg
algorithm. Hierarchical clustering was performed using aver-
age linkage and Pearson distance as a measure of similarity.
GeneOntology analysis (Functional Annotation Clustering) was
performed using the DAVID software (Huang da et al., 2009),
with the classification stringency set to high.
Results
EpiSCs derived from OG2 E6.5 embryos are in a
primed pluripotent state
EpiSCs were established from E6.5 postimplantation embryos
of OG2 heterozygous mice. OG2 mice express GFP under theFigure 1 Generation of epiblast stem cells (EpiSCs) from E6.5 pos
was dissected from E6.5 mouse embryos and cells were cultured on t
feeder layer as flat colonies. (B) Alkaline phosphatase (AP) stainingcontrol of the Oct4 promoter and distal enhancer. EpiSCs grew
on a MEF feeder layer as flat colonies reminiscent of hESCs
(Fig. 1A). Oct4 in EpiSCs is regulated by the promoter
and proximal enhancer, which is missing from the Oct4-GFP
regulatory sequence of OG2 EpiSCs (Han et al., 2010). Thus,
epiblast cells expressed Oct4-GFP in the initial stages of
culture, but expression was extinguished during subculture
(Fig. 1A). To determine whether the OG2 EpiSCs exist in a
primed pluripotent state, as reported for other EpiSC lines, we
analyzed the expression of alkaline phosphatase (AP) activity
and pluripotencymarkers, the DNAmethylation status of germ
cell marker genes, global gene expression levels, and in vitro
and in vivo differentiation potential. EpiSCs were very weakly
positive for AP compared with the strong staining exhibited by
mouse ESCs (Fig. 1B). EpiSCs were positive for Oct4 expression
by immunofluorescence staining, whereas Nanog was barely
detected (Fig. 2A). Next, we performed bisulfite genomic
sequencing to assess the DNA methylation status of the germ
cell marker Stella and the early epiblast (naive pluripotency)
marker Dppa5. We found that the promoter regions of Stellatimplantation Oct4-GFP transgenic embryos. (A) Epiblast tissue
he inactivated mouse embryonic fibroblasts. EpiSCs grew on the
was very weak in EpiSCs and strong in embryonic stem cells.
510 H.J. Jang et al.and Dppa5 were unmethylated in naive pluripotent mouse
ESCs but hypermethylated in EpiSCs (Fig. 2B). Real-time
RT-PCR analysis also revealed that expression of Oct4 mRNA
was almost the same in EpiSCs and ESCs, whereas NanogmRNA
levels were lower in EpiSCs than in ESCs. EpiSCs expressed high
levels of the epiblast markers FGF5, Sox17 and Dkk1 and much
lower levels of the ESC-specific marker, Rex1 (Fig. 2C). UponFigure 2 Characterization of epiblast stem cells (EpiSCs). (A) Immu
were strongly positive for Oct4 but very weakly positive for Nanog
and Dppa5 in EpiSCs and naive pluripotent embryonic stem cells
(C) Real-time RT-PCR analysis of EpiSCs and ESCs for pluripotency-sp
Dkk1) markers. Real-time RT-PCR data are normalized to β-actin exp
all three germ layers were present; endoderm (gut epithelium), m
bars 100 μm.injection into SCID mice testes, EpiSCs formed teratomas
containing various tissues, including gut (endoderm), muscle
(mesoderm), and neural (ectoderm) tissues, indicating that
the EpiSCs could differentiate into all three germ layers in vivo
(Fig. 2D). Taken together, these data show that EpiSCs derived
from E6.5 OG2 epiblasts meet all the criteria for primed
pluripotency.nofluorescence analyses of pluripotency markers showed EpiSCs
. (B) DNA methylation status of the promoter regions of Stella
(ESCs) was analyzed by bisulfite genomic sequencing analysis.
ecific (Oct4, Nanog, and Rex1) and EpiSC-specific (FGF5, Sox17,
ression. (D) Teratoma analysis from mouse EpiSCs. Derivatives of
esoderm (muscle fibers), and ectoderm (neural rosettes). Scale
511Derivation of NSCs from EpiSCs
To determine whether EpiSCs, like ESCs, could differentiate
into specific somatic stem cell lineages in vitro, we induced
them into NSCs. NSCs can be maintained in culture as pure
self-renewing stem cells for an extended period (Chojnacki
et al., 2009; Temple, 2001). EpiSCs were differentiated into
NSCs using a modification of previous methods (Conti et al.,
2005). EpiSCs were cultured in a neural induction medium with
high concentration of bFGF (15 ng/ml) for 1 to 2 days and
then transferred into neurosphere medium on non-adherent
culture dishes for 2 days to induce neurosphere formation
(Fig. 3A). During neural induction, EpiSCs changed their mor-
phology and formed neurosphere-like aggregates in suspension
culture (Fig. 3B). The neurosphere-like aggregates were trans-
ferred into NSC culture medium on gelatin-coated dishes and
cultured for ~1 week, at which point they form NSCs (Figs. 3A
and B). EpiSC-derived NSCs (EpiSC-NSCs) were morphologically
indistinguishable from brain-derived NSCs (Fig. 3B), could be
propagated more than passage 20 and showed positive staining
for the NSC markers, Sox2, Nestin, and Musashi (Fig. 3C). These
results therefore suggested that primed pluripotent EpiSCs
could directly differentiate into NSCs in vitro, and the EpiSC-
derived NSCs showed similarities to brain-derived NSCs.Neuronal and glial differentiation potency of
EpiSC-NSCs in vitro and in vivo
NSCs are multipotent stem cells that possess the ability
to differentiate into neurons and glial cells (astrocytesFigure 3 Generation of neural stem cells (NSCs) from epiblast stem
NSCs. (B) Morphology of neurospheres and NSCs differentiated from E
in the presence of epidermal growth factor and basic fibroblast gr
Musashi) in EpiSC-derived NSCs.and oligodendrocytes) (Gage, 2000). To determine whether
EpiSC-NSCs can differentiate into subtypes of cells in vitro,
we incubated NSCs derived from EpiSCs, brain tissue (NSCs),
or ESCs (ESC-NSCs) in neural differentiation medium (without
growth factors) for ~3 weeks. Oligodendrocytes were not
observed with this differentiation protocol. However, upon
staining with antibodies to GFAP (astrocyte marker) or Tuj1,
Map2 (neuronal marker) (Fig. S1A), we found that cells from
all three differentiated cultures contained cells positive for
GFAP (~50%) and Tuj1 (~10%) (Figs. 4A and B). About 40% of
derivatives from NSCs might be undifferentiated cells, which
were still Sox2 positive (Fig. S3). These results indicated that
EpiSC-NSCs have the ability to differentiate into neuronal
and glial cells in vitro with the same efficiency as the control
NSC and ESC-NSC lines. Next, we tested whether the EpiSC-
NSCs were able to survive and differentiate into functional
neurons and glial cells after transplantation into postnatal
mouse brains. One to 4 weeks after transplantation, we
examined the brains, especially where bisbenzimide-positive
signals were detected. Unlike human ESCs or NSCs, in which
transplanted cells can be easily detected following transplan-
tation by immunohistochemistry using antibodies against
human-specific nuclei or mitochondria, mouse-derived cells
are known to be very difficult to detect using species-specific
antibodies. To overcome this problem, mouse-derived cells
have been pre-labeled with various kinds of substances,
although they have intrinsic problems of diffusion or dilution
during cell division. In this study, we utilized bisbenzimide,
a fluorescent dye for staining DNA in the nuclei, which we
have routinely used for the detection of transplanted cells.
Although bisbenzimide-positive staining cannot guarantee thecells (EpiSCs). (A) Timeline for the differentiation of EpiSCs into
piSCs. EpiSC-derived NSCs self-renew for more than 20 passages
owth factor. (C) Expression of NSC markers (Sox2, Nestin, and
Figure 4 Differentiation potential of epiblast stem cells (EpiSCs) into neurons and glial cells in vitro and in vivo. (A) Brain-,
embryonic stem cell (ESC)-, and EpiSC-derived neural stem cells (NSCs) differentiated into neurons and glial cells in vitro, as shown by
immunofluorescence staining of the neuronal marker, Tuj1, and the glial (astrocyte) marker, glial fibrillary acidic protein (GFAP).
(B) Quantification of the lineage-specific differentiation efficiency by brain-, ESC-, and EpiSC-derived NSCs. Error bars indicate the
standard error of the mean. (C) In vivo differentiation of brain-, ESC-, and EpiSC-derived NSCs following implantation into neonatal
mouse brains. Immunohistochemical staining indicates that NSCs derived from brain (top), ESCs (middle), and EpiSC (bottom) were
positive for the neuronal marker (Tuj1) and the glial (astrocyte) marker (GFAP). Derivatives of implanted NSCs were distinguished by
bisbenzimide staining. Scale bars 20 μm.
512 H.J. Jang et al.monitoring of transplanted cells with 100% accuracy (Iwashita
et al., 2000), they can serve as a useful guideline to determine
the location of transplanted cells. Having this in mind, we
observed that transplanted NSCs could migrate into multipleFigure 5 Global gene expression profiles and Gene Ontology analy
gene expression in embryonic stem cells (ESCs), epiblast stem cells
ESC-derived neural stem cells (NSCs). (B) Hierarchical clustering an
linkage and the Pearson distance. (C) Heat map of genes upregula
downregulated in EpiSC-NSCs compared with NSCs. (E) Gene Ontolo
NSCs. (F) Gene Ontology biological process terms of the genes dow
performed using the DAVID algorithm.sites of brain and differentiate into neurons and glial cells
(Fig. S4 and S5). The migrated cells were detected as large
colonies, indicating that bisbenzimide-positive cells were not
just an artifact caused by diffusion of bisbenzimide. We alsosis of pluripotent and differentiated cells. (A) Heat map of global
(EpiSCs), mouse embryonic fibroblasts, and EpiSC-, brain-, and
alysis of the global gene expression profiles using the average
ted in EpiSC-NSCs compared with NSCs. (D) Heat map of genes
gy biological process terms of the genes upregulated in EpiSC-
nregulated in EpiSC-NSCs. Functional annotation clustering was
513
514 H.J. Jang et al.found that transplanted EpiSC-NSCs had survived and differ-
entiated into neurons and astrocytes (Fig. 4C) as well as
the transplanted brain-derived and ESC-derived NSCs. Taken
together, these results demonstrate that EpiSC-derived NSCs
can differentiate into neurons and glial cells in vitro and
in vivo with potency comparable to that of brain-derived and
ESC-derived NSCs.
Analysis of global gene expression in EpiSC-NSCs
To identify differences in the molecular signatures of
NSCs, ESC-NSCs, and EpiSC-NSCs, we analyzed their gene
expression profiles using microarrays (Illumina MouseRef-8
v2 Expression BeadChip). The microarray data showed that
the pattern of global gene expression of EpiSC-NSCs was
clearly distinct from that of pluripotent ESCs, EpiSCs, or
MEFs, another type of differentiated somatic cell (Figs. 5A
and B). Although the expression patterns of EpiSC-NSCs and
NSCs were very similar, there were differences in several
gene clusters. To identify the gene expression pattern that
was unique to EpiSC-NSCs, and not found in NSCs, we looked
for genes enriched in Gene Ontology biological processes by
screening for transcripts with a 3-fold change in expression.
We found that 114 genes were upregulated and 135
genes were downregulated in EpiSC-NSCs (Figs. 5C and D).
The Gene Ontology categories most significantly enriched in
EpiSC-NSCs were “multicellular organismal development,”
“cell development,” “generation of neurons,” “neuron
differentiation,” “transmission of nerve impulse,” and
“blood vessel morphogenesis,” which had ≥1.3 enrichment
scores with the classification stringency set to high (Fig. 5E).
On the other hand, the most significantly downregulated
transcripts in EpiSC-NSCs were “anatomical structure devel-
opment,” “regulation of response to stimulus,” “regulation of
cell death,” “positive regulation of cell death,” “chemotax-
is,” “positive regulation of cytokine production,” “response to
molecule of bacterial origin,” “immune response-activating
signal transduction,” “toll-like receptor signaling pathway,”
and “positive regulation of adaptive immune response,”which
had≥1.3 enrichment scores with the classification stringency
set to high (Fig. 5F). Of the differentially expressed genes,
only 9 were upregulated and 33 were downregulated in ESC-
NSCs compared with NSCs, and these could not be categorized
by Gene Ontology (data not shown). The Gene Ontology
cluster “developmental process” was common to the upreg-
ulated and downregulated gene sets in EpiSC-NSCs compared
with NSCs, indicating that the differentiation process of
EpiSCs into NSCs may differ from that of ESCs into NSCs
(Supplementary Table A and B). Nevertheless, the expression
profiles of most genes that are related to pluripotency,
EpiSC specificity, and NSC specificity were similarly clustered
between the cell types (Fig. S2). Given that EpiSC-NSCs and
NSCs showed the same ability to self-renew and the potential
for differentiation into neural subtypes in vivo and in vitro,
the differences in gene expression might not affect the
function of NSCs. Taken together, our results suggest that
pluripotent stem cell-derived NSCs express the same NSC
markers and have the same potential to differentiate into
neural subtypes as brain-derived NSCs. Although NSCs show
differences in their global gene expression patterns depending
on the pluripotent stem cell of origin (naive or primed), these
may not affect NSC differentiation potential.Discussion
Here, we showed that primed pluripotent stem cells, EpiSCs,
were able to differentiate into highly expandable tissue-specific
stem cells (NSCs) in vitro. These EpiSC-NSCs were morpholog-
ically similar to brain-derived NSCs, expressed NSC markers
(Nestin, Sox2, and Musashi), and could differentiate into
neurons and glial cells both in vitro and in vivo. In this respect,
EpiSC-NSCs have multipotent differentiation potential com-
parable to that of brain-derived NSCs. However, the global
gene expression patterns of the differentiated derivatives
of the primed pluripotent EpiSCs and naive pluripotent
ESCs were not the same, with the gene expression profile of
ESC-derived NSCs being closer to that of brain-derived NSCs.
These results suggest that, for in vitro differentiated cells,
the entire transcriptome of naive pluripotent stem cell-derived
NSCs (and perhaps all cell types) might be closer to that
of tissue-derived cells than cells from primed pluripotent
stem cells. Although primed pluripotent stem cells are able to
differentiate into tissue specific stem cells or differentiated
cells, details in similarity of the global gene expression patterns
are not better than naive pluripotent stem cell-derived somatic
cells, if these different gene expression patterns might not
affect functionality of the cells.
hESCs have many features that are more similar to mouse
EpiSCs than to mouse ESCs, including their morphology,
the signaling pathways required for self-renewal, and their
propensity for X chromosome inactivation (Hanna et al.,
2010b; Silva et al., 2008). Moreover, EpiSCs have differentia-
tion traits similar to both hESCs and human induced pluripo-
tent stem cells (iPSCs) (Tesar et al., 2007). Interestingly, hESCs
may bypass the tissue-specific stem cell state during in vitro
differentiation. Koch et al. showed that although it is possible
to derive hESC-derived NSCs that retain sufficient plasticity to
be recruited into different neuronal subtypes in a controlled
manner, the NSCs were not able to self-renew in long-term
culture (passage 6–10) (Koch et al., 2009). In the present
study, we established NSCs from EpiSCs that propagated more
than 20 passages, which were also obtained in brain- and
ESC-derived NSCs in the presence of EGF and bFGF (Conti
et al., 2005). These results demonstrated that, unlike human
primed pluripotent stem cells, mouse primed pluripotent
stem cells could differentiate into long-term expandable
NSCs in vitro. Recent reports have shown that primed
pluripotent hESCs and hiPSCs can convert to the naive
pluripotent state (Gu et al., 2012; Hanna et al., 2010a).
However, whether naive pluripotent hESCs can differenti-
ate into specific somatic stem cells has yet to be addressed.
In our study, EpiSCs maintained their differentiation
potential when cultured in an EpiSC medium supplemented
with activin A (20 ng/ml) and bFGF (5 ng/ml). To derive
NSCs, EpiSCs were cultured in high concentrations of bFGF
(15 ng/ml) at the initial stage of differentiation. The differen-
tiated cells formed neurospheres efficiently, which can be
also established as NSC lines later on. It was previously
shown that FGF2 signaling was inhibitory for neuroectodermal
differentiation from EpiSCs and hESCs (Greber et al., 2010,
2011). The authors suggested that inhibition of FGF2 signaling
rapidly downregulated NANOG and upregulated PAX6, leading
to neural cell generation. In contrast, a recent study showed
that sustained FGF signaling efficiently activated MAPK and
induced expression of neural markers (PAX6, SOX2) in hESCs
515(Lotz et al., 2013). Notably, FGF signaling is also essential
for self-renewal and maintenance of NSCs (Conti et al., 2005;
Xiao et al., 2007). In the present study, we showed that high
concentrations of bFGF could trigger the induction of NSC
in EpiSCs, which may provide useful clues to understanding
of cell-fate transition into the neuronal lineage from the
epiblast-stage embryos. Moreover, the mouse EpiSC-based
system may provide a useful model system to study the
development and differentiation of early post-implantation
stage human embryos, which has not previously been feasible.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2013.12.012.Author contributions
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